Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT CD22 binding agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108357